Earnings History Data for BioCardia (BCDA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioCardia

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-08-2024 AH BCDA BioCardia 5.00 -0.88 -0.10 0.00 BioCardia GAAP EPS of -$0.08 beats by $0.02, revenue of $0.03M misses by $0.02M
[8/13/2024 4:40 PM]
2.75 0.11 
(4.17%)
2.68 0.04 
(1.52%)
2.52 - 23.25 71,389 10,000 1,207
14-05-2024 AH BCDA BioCardia, Inc. 10.58 -0.09 0.00 -0.17 BioCardia GAAP EPS of -$0.09, revenue of $0.05M
[5/14/2024 4:14 PM]
0.3999 0.0 
(0.98%)
0.38 -0.01 
(-3.33%)
0.32 - 2.92 90,682 210,000 442
27-03-2024 AH BCDA BioCardia, Inc. 8.76 -0.09 -0.11 -0.16 BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M
[3/27/2024 4:17 PM]
0.4137 -0.01 
(-1.29%)
0.38 -0.04 
(-8.61%)
0.36 - 2.92 216,480 180,000 64,278
08-11-2023 AH BCDA BioCardia, Inc. 8.76 -0.12 -0.12 -0.17 BioCardia GAAP EPS of -$0.12
[11/8/2023 4:51 PM]
0.41 -0.02 
(-5.75%)
0.40 -0.04 
(-8.05%)
0.36 - 2.92 67,607 40,000 361
09-08-2023 AH BCDA BioCardia, Inc. 18.40 -0.17 -0.15 -0.14 BioCardia GAAP EPS of -$0.17, revenue of $43M
[8/9/2023 4:22 PM]
0.88 -0.03 
(-3.15%)
0.86 -0.05 
(-5.34%)
0.85 - 2.92 28,280 150,000 212
10-05-2023 AH 4:05 PM ET
(May 10)
BCDA BioCardia, Inc. 41.17 -0.17 -0.13 -0.19 BioCardia GAAP EPS of -$0.17 in-line
[5/10/2023 4:24 PM]
2.00 0.01 
(0.50%)
0.0 0.0 
(0.00%)
1.10 - 2.60 21,313 20,000 0
09-11-2022 AH 4:05 PM ET
(Nov 9)
BCDA BioCardia, Inc. 33.21 -0.17 -0.23 -0.16 BioCardia GAAP EPS of -$0.17, revenue of $0.21M
[11/9/2022 4:28 PM]
1.88 -0.04 
(-2.00%)
1.85 -0.07 
(-3.57%)
1.10 - 2.85 27,317 20,000 1,550
10-08-2022 AH 4:15 PM ET
(Aug 10)
BCDA BioCardia, Inc. 27.22 -0.14 -0.28 -0.20 1.58 0.08 
(5.07%)
1.50 0.0 
(0.00%)
1.10 - 3.96 46,015 40,000 169
11-05-2022 AH 4:05 PM ET
(May 11)
BCDA BioCardia, Inc. 22.68 -0.19 -0.15 -0.18 BioCardia GAAP EPS of -$0.19, revenue of $0.06M
[5/11/2022 4:21 PM]
1.33 0.15 
(12.71%)
1.11 -0.07 
(-5.93%)
1.10 - 5.10 149,516 110,000 711
29-03-2022 AH 4:30 PM ET
(Mar 29)
BCDA BioCardia, Inc. 36.10 -0.21 -0.21 -0.16 BioCardia GAAP EPS of -$0.75, revenue of $1M
[3/29/2022 4:21 PM]
2.07 -0.05 
(-2.36%)
2.12 0.0 
(0.00%)
1.25 - 5.10 87,895 80,000 7,669
10-11-2021 AH After the close
(Nov 10)
BCDA BioCardia, Inc. 47.75 -0.16 -0.28 -0.30 BioCardia reports Q3 results
[11/10/2021 5:14 PM]
2.55 -0.06 
(-2.12%)
2.75 -0.02 
(-0.72%)
2.00 - 8.60 33,519 30,000 101
13-05-2021 PM 8:00 AM ET
(May 13)
BCDA Biocardia, Inc. 57.00 -0.18 -0.21 0.00 BioCardia reports Q1 results
[5/13/2021 9:08 AM]
3.37 0.07 
(2.12%)
0.0 0.0 
(0.00%)
1.91 - 8.60 64,868 50,000 0
10-11-2020 PM BCDA Biocardia, Inc. 24.00 -0.30 -0.28 0.00 BioCardia EPS misses by $0.01, beats on revenue
[11/10/2020 7:22 AM]
2.05 0.13 
(6.77%)
0.0 0.0 
(0.00%)
1.91 - 6.75 41,068 57,087 0
15-05-2020 PM BCDA BioCardia, Inc. 28.01 -0.67 -0.32 -0.08 BioCardia EPS misses by $0.17
[5/15/2020 8:15 AM]
4.37 0.27 
(6.59%)
0.0 0.0 
(0.00%)
2.10 - 17.50 4,101 18,345 0